Picture of ONO PHARMACEUTICAL logo

4528 — ONO PHARMACEUTICAL News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeLarge CapSuper Stock

Table: ONO PHARMACEUTICAL -6-MTH group results (IFRS)

29 Oct 2026 03:00:12

 Oct 29 (Reuters)-
ONO PHARMACEUTICAL
 CONSOLIDATED FINANCIAL HIGHLIGHTS

 (in billions of yen unless specified)

               6 months ended  6 months ended    Year to
              Sep 30, 2026    Sep 30, 2025   Mar 31, 2027
                 LATEST         YEAR-AGO        LATEST
                RESULTS         RESULTS        FORECAST
Sales            232.50          257.14         455.00
               (-9.6 pct)      (+7.0 pct)    (-11.8 pct)
Operating        57.91           52.07          94.00
              (+11.2 pct)      (+6.7 pct)     (+1.9 pct)
Pretax           58.42           52.18          94.00
              (+12.0 pct)      (+9.7 pct)     (+1.5 pct)
Net              44.93           40.09          71.00
              (+12.1 pct)      (+7.1 pct)     (+1.8 pct)
EPS Basic      95.60 yen       85.33 yen      151.09 yen
EPS Diluted    95.49 yen       85.28 yen          --
Ann Div            --          80.00 yen      80.00 yen
-Q2 div        40.00 yen       40.00 yen          --
-Q4 div            --          40.00 yen      40.00 yen


 NOTE - ONO PHARMACEUTICAL.
(Figures are reported based on international accounting rules (IFRS).)

If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half
dividend and Q4 to the second-half dividend announced before a new corporate law in
 2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company.
 To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T

Recent news on ONO PHARMACEUTICAL

See all news